Philip Morris International Inc (PM) 82.96

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Philip Morris International Inc (PM) 82.96 $PM

Impeccable Quality But There Are No Bargains Today In The S&P 500 Consumer Staples Sector: Part 8
Chuck Carnevale - at Seeking Alpha - Wed Feb 25, 11:00AM CST

WFM: 56.49 (-0.24), KO: 43.30 (+0.84), DPS: 78.79 (+0.60), PM: 82.96 (+0.16), AVP: 8.51 (+0.12), MKC: 75.38 (unch), CAG: 34.98 (+0.31), CVS: 103.87 (-0.30), COST: 146.96 (+0.31), PG: 85.13 (-0.04), GIS: 53.79 (+0.37), BF.B: 91.69 (-0.73)

DGI 2015 Candidate Buy List - Added 10 Consumer Staples Stocks
Earl Setser - at Seeking Alpha - Tue Feb 24, 4:28PM CST

RAI: 75.62 (-0.01), KO: 43.30 (+0.84), BTI: 116.47 (-0.53), CLX: 108.64 (-0.46), KMB: 109.66 (-0.25), LO: 68.42 (-0.06), MO: 56.29 (+0.20), UVV: 47.91 (-0.04), K: 64.48 (-0.19), PEP: 98.98 (-0.09), PM: 82.96 (+0.16), NUS: 54.18 (-2.06), PG: 85.13 (-0.04), FLO: 21.64 (+0.21), GIS: 53.79 (+0.37)

Philip Morris International: 3 Trends To Watch Going Forward Revisited
Rupert Hargreaves - at Seeking Alpha - Tue Feb 24, 2:38PM CST

PM: 82.96 (+0.16)

Beating The Little Book That Beats The Market
Kyle Pinkerton - at Seeking Alpha - Tue Feb 24, 10:41AM CST

SAFM: 85.21 (-0.46), WMT: 83.93 (+0.13), USNA: 100.01 (-4.97), INTC: 33.25 (-0.40), LYB: 85.91 (-0.84), OCIR: 24.30 (+0.10), TSRA: 40.06 (+0.04), DTV: 88.60 (+0.25), MSFT: 43.85 (-0.21), DLX: 66.55 (-1.40), AAPL: 128.46 (-1.95), HRB: 34.15 (-0.33), KO: 43.30 (+0.84), WLK: 66.76 (-0.61), NTES: 100.04 (-4.70), MAN: 80.46 (-1.05), WNR: 47.10 (+0.04), ALK: 63.65 (-0.33), CMP: 90.67 (+0.35), PM: 82.96 (+0.16), HCA: 71.54 (-0.73), BBBY: 74.66 (+0.91), CALM: 37.63 (+0.17), TJX: 68.64 (+0.57), AZO: 642.68 (-2.29), GILD: 103.53 (-0.66), TARO: 151.06 (-2.07), PINC: 36.66 (+0.02), NTL: 22.85 (+0.05)

Imperial Tobacco Now Appears Fully Priced
Timberwolf Equity Research - at Seeking Alpha - Sat Feb 21, 6:44AM CST

RAI: 75.62 (-0.01), PM: 82.96 (+0.16), BTI: 116.47 (-0.53), LO: 68.42 (-0.06), MO: 56.29 (+0.20)

Altria Maintains FY15 Outlook, Plans to Ship MarkTen Abroad - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 5:09PM CST
Tobacco maker Altria Group Inc. (MO) maintained its previously provided fiscal 2015 earnings guidance during the Consumer Analyst Group of New York Conference held on Feb 19, 2015.
RAI: 75.62 (-0.01), PM: 82.96 (+0.16), LO: 68.42 (-0.06), MO: 56.29 (+0.20)

Elisa D. Garcia C. Joins Dollarama Board of Directors
CNW Group - Thu Feb 19, 6:30AM CST
Dollarama Inc. ("Dollarama" or the "Corporation" (TSX: DOL) is pleased to announce that its Board of Directors appointed Elisa D. Garcia C. as an independent director and member of the Nominating and Governance Committee of the Corporation, effective February 18, 2015. Ms. Garcia's appointment expands the Corporation's Board of Directors to ten directors, seven of whom are independent.
PM: 82.96 (+0.16), ODP: 9.37 (+0.07), DOL.TO: 62.52 (-0.72)

Philip Morris: An Update Regarding 2015
Bill Maurer - at Seeking Alpha - Wed Feb 18, 11:47PM CST

PM: 82.96 (+0.16)

Philip Morris' (PM) CEO Jacek Olczak Presents at CAGNY 2015 Conference (Transcript)
SA Transcripts - at Seeking Alpha - Wed Feb 18, 8:29PM CST

PM: 82.96 (+0.16)

Philip Morris International Inc. Presents at the Consumer Analyst Group of New York (CAGNY) Conference
Business Wire - Wed Feb 18, 12:35PM CST
Regulatory News:
PM: 82.96 (+0.16)

Philip Morris: A 5% Dividend Nugget With An Intrinsic Value Of $100+
Achilles Research - at Seeking Alpha - Tue Feb 17, 3:27PM CST

PM: 82.96 (+0.16), LO: 68.42 (-0.06), MO: 56.29 (+0.20)

Why Philip Morris International Is a Hidden Gem
Bob Ciura, The Motley Fool - Motley Fool - Tue Feb 17, 1:17PM CST
PMI Manufacturing Facility. Source: Company website. Currencies are causing a major headache for multinational companies. Domestic companies that do business outside the United States are seeing their revenue and profits artificially slashed by...
PM: 82.96 (+0.16), MO: 56.29 (+0.20)

My Dividend Income Portfolio Update
Mark Farragher - Seeking Alpha - Tue Feb 17, 3:10AM CST
Six months ago , I decided to become a Dividend Growth Investor and become financially independent. Every month on the 8th and the 24th, I have invested €1000 in new stocks. If I keep this up, 15 years from now , my stock portfolio will grow...
NOV: 54.35 (+1.08), PM: 82.96 (+0.16), RDS.B: 68.15 (+0.44), RDS.A: 65.37 (+0.55), AAPL: 128.46 (-1.95)

10 Dividend Growth Stocks For February 2015
FerdiS - at Seeking Alpha - Mon Feb 16, 8:36AM CST

ARLP: 39.55 (+0.30), CNP: 20.79 (-0.23), HP: 67.06 (+0.86), TGH: 32.26 (-0.81), BNS: 53.45 (+0.30), TUP: 71.40 (-0.79), JNJ: 102.51 (-0.29), PM: 82.96 (+0.16), ALB: 56.57 (+0.27), GMLP: 26.11 (-0.13), TAL: 41.73 (-0.82), TU: 35.56 (-0.03), MSFT: 43.85 (-0.21), BBL: 50.20 (+0.28)

Tracking Tweedy Browne's Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Sat Feb 14, 11:31AM CST

KOF: 86.30 (-1.99), DNOW: 21.25 (-0.10), CNQ: 29.15 (-0.34), WMT: 83.93 (+0.13), GOOG: 558.40 (+2.92), DEO: 118.85 (+0.14), BSBR: 4.98 (-0.04), NOV: 54.35 (+1.08), FII: 32.93 (-0.50), CSCO: 29.51 (-0.40), MA: 90.13 (-1.13), PSX: 78.46 (-1.60), TMK: 53.25 (-0.22), UN: 43.47 (+0.22), HAL: 42.94 (+0.24), AGCO: 49.74 (-0.21), COP: 65.20 (-0.65), WFC: 54.79 (-0.36), GSK: 47.42 (-0.42), UL: 44.11 (+0.06), CTWS: 37.10 (-0.58), NWLI: 251.38 (-3.19), RDS.A: 65.37 (+0.55), ANAT: 104.75 (-1.10), BRK.B: 147.41 (-0.93), BRK.A: 221,180.00 (-1,070.00), NVS: 102.40 (-0.60), MMM: 168.65 (-0.96), LMT: 200.05 (-1.28), UNF: 118.83 (-1.86), XOM: 88.54 (-0.11), SHEN: 29.09 (-0.57), JNJ: 102.51 (-0.29), GOOGL: 562.63 (+3.34), BK: 39.14 (-0.30), UNP: 120.26 (-0.50), JOY: 44.32 (-0.40), DVN: 61.59 (-0.96), AXP: 81.59 (-1.66), EMR: 57.92 (-0.02), HSBC: 44.62 (-0.23), ITW: 98.86 (-0.45), PM: 82.96 (+0.16), BRO: 32.14 (-0.22), TOT: 53.63 (+0.65), USB: 44.61 (-0.32), BAX: 69.15 (+0.48), CMCSA: 59.38 (+0.23), VZ: 49.45 (+0.08)

The Extraordinary Story of America’s Most Successful Industry
Morgan Housel, The Motley Fool - Motley Fool - Fri Feb 13, 10:10AM CST
Source: S&P Capital IQ Take a look at this chart. It shows the performance of the most successful company in the world. One dollar invested in this company in 1968 was worth $6,638 yesterday (including dividends). That's an annual return of...
PM: 82.96 (+0.16), MO: 56.29 (+0.20), AAPL: 128.46 (-1.95)

3 High-Yielding Dividend Stocks That Are Actually Safe
Motley Fool Staff - Motley Fool - Fri Feb 13, 7:01AM CST
High-yield dividend stocks can be great for income investors, but many of them can be too good to be true. Many high dividends are a sign that a company is in trouble, or won't be able to sustain the payout in the future. And others are a sign that...
PM: 82.96 (+0.16), HCP: 42.36 (+0.58), FII: 32.93 (-0.50), KRFT: 64.06 (+0.28), NPK: 60.64 (-1.43), MO: 56.29 (+0.20)

Why Income Investors Should Be All Over Philip Morris International
Bob Ciura - at Seeking Alpha - Thu Feb 12, 7:37PM CST

PM: 82.96 (+0.16), MO: 56.29 (+0.20)

Philip Morris Continues To Offer Significant Price Appreciation And Future Growth
Equity Watch - at Seeking Alpha - Thu Feb 12, 6:33PM CST

PM: 82.96 (+0.16), LO: 68.42 (-0.06), MO: 56.29 (+0.20)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mazu Culture Forum Unveils New Initiatives in China

Updated Category News Views 126

A Cultural Tapestry Unfurls in Putian Picture this: a kaleidoscope of cultures and ideas unraveling in the coastal city of Putian. The 11th Global Mazu Culture Forum kicks off on October 31, bringing together minds—both fresh and seasoned—from an impressive array of 47 countries and regions. It's more than a forum; it's a vibrant crossroads of innovation, tradition,...

Continue Reading
Foxconn Spotlights AI Advancements at Tech Day 2026

Updated Category News Views 127

Foxconn's Bold Step into AI Infrastructure Foxconn, the tech giant that most folks recognize for its sheer prowess in electronics manufacturing, isn't just idling on past laurels. During the 7th annual Hon Hai Tech Day 2026, it was a showcase of fireworks that left attendees buzzing about the future of AI infrastructure and beyond. And when Foxconn says it's transforming,...

Continue Reading
Haunted Attraction Insights from the Queen of Haunts

Updated Category News Views 5

Admit it—everyone's got that one fear that sends shivers down their spine. Whether it's the slithering scales of a snake or the manic laughter of a clown, those phobias are what make haunted attractions such a hit for thrillseekers across the country. Amber Arnett-Bequeaith, the so-called Queen of Haunts, knows a thing or two about turning those fears into unforgettable...

Continue Reading
European Doctors Explore Chinese Aesthetic Innovations

Updated Category News Views 39

Pioneering Exchange in Regenerative Aesthetics Ever seen European doctors flocking to China to learn about beauty techniques? That's the scene as aphranel®, the brainchild of MOYOM Biotech, ushers in a week-long clinical exchange under 'The Norns' Weave.' The whole deal aims to unravel how Chinese practices could shape Europe's aesthetic landscape. Yep, it's all about...

Continue Reading
Gooru AI Unveils Platform to Scale Human Expertise

Updated Category News Views 67

A New Wave of AI-Powered Solutions Hot off the press, Gooru AI's recent shindig in the heart of Dallas aimed to showcase something they call 'Digital Goorus.' Now that might sound like a newage tech gimmick but peel back the layers and you find an ambitious attempt to let folks spread their smarts without having to be everywhere all at once. Imagine being able to crack...

Continue Reading
Nanoscope Therapeutics Aims for Eye-Catching Advances

Updated Category News Views 69

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Continue Reading
Okta Joins S&P 500 Amidst Major Index Shuffles

Updated Category News Views 172

Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...

Continue Reading
MediaGo Wins Big in France with Optimized Strategies

Updated Category News Views 75

MediaGo's Winning Edge in Advertising Shake the dust off your boots and get ready for a tale of triumph straight out of San Francisco. MediaGo, the top dog in global intelligent advertising platforms, just added a couple of shiny awards to its trophy case thanks to the prestigious Les Cas d'OR 2026 in France. And let me tell ya, these wins aren't just about some pretty...

Continue Reading
Lecanemab's New Data: What Investors Should Monitor

Updated Category News Views 71

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Continue Reading
Fintech Shake-Up: OPay's $4B NYSE IPO Arrival

Updated Category News Views 33

It's a big day on Wall Street as OPay dives into the NYSE with a hefty market cap of over $4 billion, signaling a major moment for the fintech arena. Oh, how times are shifting! Today marks the debut of OPay under the ticker 'OPAY,' and let me tell you, there's a buzz in the air that could quicken any seasoned trader's pulse. OPay's Big Day: A New Era of Fintech Their...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Consumer Product Risks: Insights from Legal Experts

Updated Category News Views 131

Investigation into Defective Consumer Products The Law Offices of Jason Turchin is currently investigating various claims related to defective consumer products that can potentially harm individuals. These products include commonly used items such as space heaters and HVAC systems, as well as kitchen equipment like coffee makers and pressure cookers. Each of these items...

Continue Reading
Nauticos Takes Bold Steps Toward Uncovering Earhart's Mystery

Updated Category News Views 303

Nauticos Aims to Solve a Historic Mystery Nauticos, a leader in deep-sea exploration and historical research, has announced an exciting new expedition to locate Amelia Earhart's Lockheed Electra. This groundbreaking mission is fueled by proprietary data that pinpoints the likely resting place of the iconic aircraft. The research advances our understanding of where Earhart...

Continue Reading
Equitable Bank Achieves Historic $300 Million Deposit Note Success

Updated Category News Views 197

Equitable Bank Closes Impressive $300 Million Deposit Note Issuance Equitable Bank, Canada's Challenger Bank™, has successfully closed a monumental $300 million floating rate deposit note issuance. This remarkable achievement marks the tightest spread on record for deposit notes of a similar term issued by the bank. The overwhelming response from investors demonstrates...

Continue Reading
Exploring the Long-Term Gains of Sprouts Farmers Market Stock

Updated Category News Views 98

Understanding the Growth of Sprouts Farmers Market Stock Over the last decade, Sprouts Farmers Market (NASDAQ: SFM) has demonstrated remarkable growth, consistently surpassing market returns by an impressive 3.05% annually. With average annual returns reaching 14.93%, this company's performance is a topic of great interest among investors. Initial Investment Insights...

Continue Reading
Anticipating Royalty Pharma's First Quarter 2025 Financial Results

Updated Category News Views 119

Upcoming Financial Results Announcement Royalty Pharma plc (Nasdaq: RPRX) is gearing up to share its financial journey for the first quarter of 2025 on May 8, 2025. As one of the largest buyers of biopharmaceutical royalties, the firm is set to unveil its latest financial results early in the day, prior to the opening of U.S. markets. This announcement will give investors...

Continue Reading